Malignant Infantile Osteopetrosis : Opportunities, Demand and Foreca Malignant Infantile Osteopetrosis Healthcare | Page 4

Malignant Infantile Osteopetrosis Market
Malignant Infantile osteopetrosis is also called as infantile autosomal recessive
osteopetrosis. It is one of the rare skeletal dysplasia that is characterized using a
radiographic pattern which shows increased bone density with involvement of the
medullary portion. This type of disease typically manifests in infancy. Diagnosis of
Malignant Infantile Osteopetrosis is based on radiographic evaluation and clinical
evaluation, that is further confirmed using gene analysis technique if required. Due
to medullary canal eradication and bony expansion, cranial nerve compression,
grave pancytopenia, and fractures may ensue. It condition of the patient becomes
more critical if untreated for a longer time period. Defect in one or more genes that
are involved in functioning, formation and development of cells leads to
osteopetrosis. This diseased condition involves some significant symptoms viz.
blurring of vision, bone fractures, low blood cells level and recurrent dental infection.
The global Malignant Infantile Osteopetrosis Market is segmented on the
basis of types of disease, type of test and end user.
On the basis of Medication type, the global Malignant Infantile
Osteopetrosis Market is segmented into:
©2015 Future Market Insights, All Rights
Reserved
4